Division of Gastroenterology & Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada.
Department of Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
J Hepatol. 2018 Sep;69(3):608-616. doi: 10.1016/j.jhep.2018.04.015. Epub 2018 Apr 28.
BACKGROUND & AIMS: Two major body compartments, skeletal muscle and adipose tissue, exhibit independent functions. We aimed to explore the prognostic significance of skeletal muscle, visceral and subcutaneous adipose tissue, according to sex, in patients with cirrhosis assessed for liver transplantation (LT).
CT images taken at the 3rd lumbar vertebra from 677 patients were quantified for three body composition indexes (cm/m), visceral adipose tissue index, subcutaneous adipose tissue index (SATI), and skeletal muscle index (SMI). Cox proportional and competing-risk analysis hazard models were conducted to assess associations between mortality and body composition.
The majority of patients were male (67%) with a mean age of 57 ± 7 years, model for end-stage liver disease (MELD) score of 14 ± 8 and mean body mass index of 27 ± 6 kg/m. Despite similar body mass index between the sexes, male patients had greater SMI (53 ± 12 vs. 45 ± 9 cm/m), whereas SATI (67 ± 52 vs. 48 ± 37 cm/m) was higher in females (p <0.001 for each). In sex stratified multivariate analyses after adjustment for MELD score and other confounding variables, SATI in females (hazard ratio [HR] 0.99; 95% CI 0.98-1.00; p = 0.01) and SMI in males (HR 0.98; 95% CI 0.96-1.00; p = 0.02) were significant predictors of mortality. Female patients with low SATI (<60 cm/m) had a higher risk of mortality (HR 2.06; 95% CI 1.08-3.91; p = 0.03). Using competitive risk analysis in female patients listed for LT, low SATI was also an independent predictor of mortality (subdistribution HR 2.80; 95% CI 1.28-6.12; p = 0.01) after adjusting for MELD, and other confounding factors.
A lower SATI is associated with higher mortality in female patients with cirrhosis. Subcutaneous adipose tissue has a favorable metabolic profile - low SATI may reflect depletion of this major energy reservoir, leading to poor clinical outcomes.
We looked at the importance of two of the main body compartments, skeletal muscle and adipose tissue (fat) on the prognosis of males and females with end-stage liver disease. Lower amounts of subcutaneous fat but not visceral fat (around internal organs), are associated with higher mortality in female patients with end-stage liver disease. However, low skeletal muscle predicts mortality in male patients with end-stage liver disease.
骨骼肌和脂肪组织是两个主要的身体组织,它们具有独立的功能。我们旨在根据性别探讨骨骼肌、内脏和皮下脂肪组织在评估肝移植(LT)的肝硬化患者中的预后意义。
对 677 名患者的第 3 腰椎 CT 图像进行了 3 个体成分指数(cm/m)、内脏脂肪组织指数、皮下脂肪组织指数(SATI)和骨骼肌指数(SMI)的定量分析。采用 Cox 比例风险和竞争风险分析危险模型评估死亡率与身体成分之间的关系。
大多数患者为男性(67%),平均年龄为 57±7 岁,终末期肝病模型(MELD)评分为 14±8,平均体重指数为 27±6kg/m。尽管男女的体重指数相似,但男性的 SMI 更高(53±12 与 45±9cm/m),而女性的 SATI 更高(67±52 与 48±37cm/m,p<0.001)。在按性别分层的多变量分析中,在校正 MELD 评分和其他混杂因素后,女性的 SATI(风险比 [HR]0.99;95%置信区间 [CI]0.98-1.00;p=0.01)和男性的 SMI(HR0.98;95%CI0.96-1.00;p=0.02)是死亡率的显著预测因素。女性中 SATI 较低(<60cm/m)的患者死亡率风险更高(HR2.06;95%CI1.08-3.91;p=0.03)。在接受 LT 治疗的女性患者中使用竞争风险分析,低 SATI 也是死亡率的独立预测因素(亚分布 HR2.80;95%CI1.28-6.12;p=0.01),在调整了 MELD 评分和其他混杂因素后也是如此。
SATI 较低与肝硬化女性患者死亡率较高相关。皮下脂肪组织具有良好的代谢特征-低 SATI 可能反映了这种主要能量储存的消耗,导致不良的临床结局。
研究人员观察了两个主要身体组织(骨骼肌和脂肪组织)对男性和女性终末期肝病患者预后的重要性。终末期肝病女性患者的皮下脂肪量较低,但内脏脂肪量(围绕内部器官)不低,与死亡率较高相关。然而,低骨骼肌则预示着终末期肝病男性患者的死亡率。